March 2024: Moleac Pte Ltd announced a study of Phase 4 clinical trials for NeuroAiD. SATURN investigates the promising role ...

Antibody NG101 enhances motor recovery in spinal cord injury patients, marking progress in rehabilitation research.

Onward Medical today announced the first commercial sales of its ARC-EX spinal cord stimulation system (SCS) in the U.S.

In a groundbreaking development that could change the lives of thousands of people with spinal cord injuries, European ...

NG101 was generally safe with no treatment-related deaths reported. For individuals with recent acute cervical spinal cord injuries, treatment with a novel neuroregenerative therapeutic was ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Degenerative cervical myelopathy (DCM) is a clinical condition of upper motor neuron lesion signs, that is confirmed with advanced imaging demonstrating compression of the spinal cord in the cervical ...

More information: Norbert Weidner et al, Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre ...

More information: Marcel A. Kopp et al, Hospital-Acquired Pressure Ulcers and Long-Term Motor Score Recovery in Patients With Acute Cervical Spinal Cord Injury, JAMA Network Open (2024).